Cargando…

Health care costs of rheumatoid arthritis: A longitudinal population study

Quantifying the contribution of rheumatoid arthritis to the acquisition of subsequent health care costs is an emerging focus of the rheumatologic community and payers of health care. Our objective was to determine the healthcare costs before and after diagnosis of rheumatoid arthritis (RA) from the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tatangelo, Mark, Tomlinson, George, Paterson, J Michael, Keystone, Edward, Bansback, Nick, Bombardier, Claire
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101709/ https://www.ncbi.nlm.nih.gov/pubmed/33956894 http://dx.doi.org/10.1371/journal.pone.0251334

Ejemplares similares

Comorbidities Before and After the Diagnosis of Rheumatoid Arthritis: A Matched Longitudinal Study
por: Tatangelo, Mark R., et al.
Publicado: (2020)

Association of Patient, Prescriber, and Region With the Initiation of First Prescription of Biologic Disease-Modifying Antirheumatic Drug Among Older Patients With Rheumatoid Arthritis and Identical Health Insurance Coverage
por: Tatangelo, Mark, et al.
Publicado: (2019)

Discontinuation of tofacitinib and TNF inhibitors in patients with rheumatoid arthritis: analysis of pooled data from two registries in Canada
por: Movahedi, Mohammad, et al.
Publicado: (2023)

Rituximab for Rheumatoid Arthritis
por: Cohen, Marc D., et al.
Publicado: (2015)

ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI)
por: Pope, Janet E, et al.
Publicado: (2018)

Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort
por: Movahedi, Mohammad, et al.
Publicado: (2022)

Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis
por: Hazlewood, Glen S, et al.
Publicado: (2016)

Late-onset rheumatoid arthritis has a similar time to remission as younger-onset rheumatoid arthritis: results from the Ontario Best Practices Research Initiative
por: Li, Xiuying, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on patients with rheumatoid arthritis: data from the Ontario Best Practices Research Initiative (OBRI)
por: Wong-Pack, Matthew, et al.
Publicado: (2023)

Cardiovascular risk factors are negatively associated with rheumatoid arthritis disease outcomes
por: Cui, Kangping, et al.
Publicado: (2021)

Validity of the work productivity and activity impairment questionnaire - general health version in patients with rheumatoid arthritis
por: Zhang, Wei, et al.
Publicado: (2010)

Somatic mutations in the mitochondria of rheumatoid arthritis synoviocytes
por: Da Sylva, Tanya R, et al.
Publicado: (2005)

Adaptation of a Shared Decision-Making Tool for Early Rheumatoid Arthritis Treatment Decisions with Indigenous Patients
por: Umaefulam, Valerie, et al.
Publicado: (2021)

Measuring a grey area in medication deployment reveals delays from invention to clinical use of rheumatoid arthritis medications
por: Tatangelo, Mark
Publicado: (2022)

Preventing rheumatoid arthritis: Preferences for and predicted uptake of preventive treatments among high risk individuals
por: Harrison, Mark, et al.
Publicado: (2019)

Impact of etanercept tapering on work productivity in patients with early rheumatoid arthritis: results from the PRIZE study
por: Zhang, Wei, et al.
Publicado: (2016)

TNFα modulates protein degradation pathways in rheumatoid arthritis synovial fibroblasts
por: Connor, Alison M, et al.
Publicado: (2012)

Access to rheumatologists among patients with newly diagnosed rheumatoid arthritis in a Canadian universal public healthcare system
por: Widdifield, Jessica, et al.
Publicado: (2014)

An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: the influence of the reference standard on algorithm performance
por: Widdifield, Jessica, et al.
Publicado: (2014)

Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): Results from the CanACT study
por: Haraoui, Boulos, et al.
Publicado: (2011)

Effectiveness and costs of multidisciplinary care in patients with rheumatoid arthritis
por: Verstappen, S.M.M.
Publicado: (2003)

Direct costs of rheumatoid arthritis multidisciplinary care in Ireland
por: Priyadarshini, A, et al.
Publicado: (2023)

Development of an Implementation Strategy for Patient Decision Aids in Rheumatoid Arthritis Through Application of the Behavior Change Wheel
por: Barber, Claire E. H., et al.
Publicado: (2021)

Making smart investment decisions in clinical research
por: Bansback, Nick, et al.
Publicado: (2015)

Burden of rheumatoid arthritis among US Medicare population: co-morbidities, health-care resource utilization and costs
por: Chen, Chieh-I, et al.
Publicado: (2018)

Indirect costs of rheumatoid arthritis
por: Raciborski, Filip, et al.
Publicado: (2015)

Geographic Variation in the Quality and Cost of Care for Patients with Rheumatoid Arthritis
por: Shafrin, Jason, et al.
Publicado: (2016)

Long-Term Safety of Subcutaneous Abatacept in Rheumatoid Arthritis: Integrated Analysis of Clinical Trial Data Representing More Than Four Years of Treatment
por: Alten, Rieke, et al.
Publicado: (2014)

Estimating the monetary value of the annual productivity gained in patients with early rheumatoid arthritis receiving etanercept plus methotrexate: interim results from the PRIZE study
por: Zhang, Wei, et al.
Publicado: (2015)

Characterization of active joint count trajectories in juvenile idiopathic arthritis
por: Berard, Roberta A, et al.
Publicado: (2012)

Modified Disease Activity Score at 3 Months Is a Significant Predictor for Rapid Radiographic Progression at 12 Months Compared With Other Measures in Patients With Rheumatoid Arthritis
por: Movahedi, Mohammad, et al.
Publicado: (2020)

Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate
por: Cohen, Stanley B, et al.
Publicado: (2010)

Reduction in Serum Uric Acid May Be Related to Methotrexate Efficacy in Early Rheumatoid Arthritis: Data from the Canadian Early Arthritis Cohort (CATCH)
por: Lee, Jason J., et al.
Publicado: (2016)

Cost-Effectiveness of Repository Corticotropin Injection versus Standard of Care for the Treatment of Active Rheumatoid Arthritis
por: Bindra, Jas, et al.
Publicado: (2021)

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
por: Pers, Yves-Marie, et al.
Publicado: (2011)

Impact of residential area on the management of rheumatoid arthritis patients initiating their first biologic DMARD: Results from the Ontario Best Practices Research Initiative (OBRI)
por: Movahedi, Mohammad, et al.
Publicado: (2019)

Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis
por: Keystone, Edward C, et al.
Publicado: (2018)

Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis
por: Emery, Paul, et al.
Publicado: (2011)

Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritis
por: Smolen, Josef S, et al.
Publicado: (2020)

Using a Discrete-Choice Experiment in a Decision Aid to Nudge Patients Towards Value-Concordant Treatment Choices in Rheumatoid Arthritis: A Proof-of-Concept Study
por: Hazlewood, Glen S, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h9kfe1raklg8i4nebk05klbja4